Skip to content

A clinical trial to study the effect of dexmetomidine as an adjuvant to 0.2% ropivacaine in erector spinae plane block for operative pain relieve in participants undergoing total abdominal hysterectomies

To study the effect of Dexmetomidine as adjuvant to 0.2 % Ropivacaine in Erector Spinae Plane block for post operative analgesia in total abdominal hysterectomies. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071636
Enrollment
70
Registered
2024-07-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Patient receiving block with dexmedetomidine: Patients will receive ultrasound guided bilateral ESP block at T10 vertebrae level . Drug solution will contain 40 ml of 0.2 % ropivacaine

Sponsors

Dayanand Medical College and Hospital, Ludhiana
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.American Society of Anaesthesiologists (ASA) I-III 2.Adults (30 to 70 years of age) 3.Female sex 4. Total abdominal hysterectomy patients with infra umblical incision

Exclusion criteria

Exclusion criteria: 1.Refusal for inclusion in study 2.Local anaesthetic allergy / or previous anaphylactic shock from the same 3.Infection at block site 4.Patients with history of opioid abuse 5. Patients who are unable to comprehend VAS score

Design outcomes

Primary

MeasureTime frame
The time at which patient requests for first rescue analgesic in post-operative period.Timepoint: The time at which patient requests for first rescue analgesic in post-operative period in first 24 hours

Secondary

MeasureTime frame
Total opioid consumption in 24 hours Bidirectional Visual Analogue Scale (VAS) score will be recorded at rest and on movement at designated intervals. 3)QoR -15 (Quality of Recovery) questionnaire will be accessed in post-operative period during the time of discharge from PACU . Timepoint: 24 hours

Countries

India

Contacts

Public ContactDr Rachita

Dayanand Medical College and Hospital

shivbro2001@gmail.com7973722987

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026